Artelo Biosciences Inc. logo

Artelo Biosciences Inc.

ARTL | NASDAQ
Chart Builder DCF Calculator
$4.15
+$0.05 (+1.22%)
At close: Sep 22, 2026, 4:00 PM ET
$4.11
-$0.04 (-0.94%)
After-hours: Sep 22, 2026, 7:59 PM ET

Market Data

Market Cap
$1.59M
Enterprise Value
$-2.56M
Beta
-0.08
Average Volume
112.33K
Shares Outstanding (Diluted)
2.71M
Shares Change YoY
57.49%
Institutional Ownership
6.17%
Exchange
NASDAQ
ISIN
US04301G8050

Price Performance

Price Change 1M
-32.9%
Price Change 3M
-63.8%
Price Change 6M
-90.6%
Price Change YTD
-64.1%
Price Change 1Y
-92.3%
Price Change 3Y
-95.1%
Price Change 5Y
-99.4%
1M CAGR (ann.)
-36.8%
1Y CAGR (ann.)
-91.8%
5Y CAGR (ann.)
-64.3%
All-Time CAGR
-60.9%

Valuation

PE Ratio
-0.50
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.00
PS Ratio
N/A
Forward PS
0.00
PB Ratio
0.32
P/FCF Ratio
-0.13
P/Adj. FCF Ratio
-0.11
P/OCF Ratio
-0.10
EV/Sales
N/A
EV/EBIT
0.21
EV/EBITDA
0.21
EV/FCF
0.20
Earnings Yield
-201.2%
FCF Yield
-795.6%
Adj. FCF Yield
-907.1%

Financial Health

Net Cash
$4.15M
Total Debt
$49K
Cash & Short-Term Investments
$4.2M
Total Assets
$6.46M
Current Ratio
3.00
Quick Ratio
3.00
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
-257.82
Interest Coverage
-17.91
Altman Z-Score
-19.79
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-14.0%

Returns

Return on Assets
-196.2%
Return on Equity
-519.1%
Return on Invested Capital
-219.4%
Return on Capital Employed
-221.2%
Return on Tangible Assets
-286.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-53.5%
EPS CAGR 5Y
-51.5%
EPS CAGR 10Y
-8.5%
FCF CAGR 3Y
-17.7%
FCF CAGR 5Y
-9.4%
FCF CAGR 10Y
-19.5%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
1
EPS Growth Next 3Y
1129.7%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 16, 2026
EPS Estimate (next Q)
-$7.02
EPS Growth Est (next Q)
-41.1%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-12.63M
Free Cash Flow
$-12.63M
Adj. Free Cash Flow
$-14.4M
FCF Per Share
-$41.92
OCF Per Share
-$41.92
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$0
Operating Income
$-11.07M
EBITDA
$-12.05M
Net Income
$-12.67M
EPS (Diluted)
-$8.25
Revenue / Employee
N/A
Profit / Employee
$-1.81M
Employees
7

© 2026 bestshares.com. All rights reserved.